Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Intellia Therapeutics Inc buy Chardan Capital

Intellia Therapeutics Inc
Start price
€7.60
09.05.25 / 50%
Target price
€60.64
09.05.26
Performance (%)
59.47%
End price
€12.12
10.05.26
Summary
This prediction ended on 10.05.26 with a price of €12.12. With a performance of 59.47% the BUY prediction by Chardan_Capital was a big success. Chardan_Capital has a follow-up prediction for Intellia Therapeutics Inc where he still thinks Intellia Therapeutics Inc is a Buy. Chardan_Capital has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Intellia Therapeutics Inc -3.654% -3.654% 8.984%
iShares Core DAX® -0.874% 5.325% 6.865%
iShares Nasdaq 100 -0.381% 1.979% 25.696%
iShares Nikkei 225® -1.676% 1.952% 41.443%
iShares S&P 500 -0.655% 2.069% 21.405%

Comments by Chardan_Capital for this prediction

In the thread Intellia Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) 59.47%
Target price 60.636
Change
Ends at 09.05.26

Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $68.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat

Chardan Capital 
0
Report Share
09.05.25
In the thread Trading Intellia Therapeutics Inc
Prediction Buy
Perf. (%) 59.47%
Target price 60.636
Change
Ends at 09.05.26

Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten

Chardan Capital 
0
Report Share
10.05.26

Current prediction by Chardan_Capital for Intellia Therapeutics Inc

buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€12.31
27.10.25
€41.25
27.10.26
-18.60%
18.08.26

Chardan Capital 
27.10.25 50%

Stopped prediction by Chardan_Capital for Intellia Therapeutics Inc

buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€11.76
27.04.26
€25.58
27.04.27
-14.80%
18.08.26

Chardan Capital 
27.04.26 50%
buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€11.72
27.02.26
€22.04
27.02.27
-14.51%
18.08.26

Chardan Capital 
27.02.26 50%
buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€9.69
28.02.25
€65.29
28.02.26
13.42%
01.03.26

Chardan Capital 
28.02.25 50%
buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€13.46
18.11.24
€86.10
18.11.25
-46.48%
19.11.25

Chardan Capital 
18.11.24 50%
buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€35.98
07.08.23
€97.28
07.08.24
-45.29%
08.08.24

Chardan Capital 
07.08.23 50%